7 Genetics and Population Health Division, Queensland Institute of Medical Research, Brsibane, Queensland, Australia 8 School of Population Health, University of Queensland, Herston, Queensland, ...

Pathology Department, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgium Correspondence to Professor F A Houssiau, Rheumatology Department, Cliniques ...

Objective To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares with other ...

8 Faculty of Medicine, University of NSW, Sydney, New South Wales, Australia 9 Department of Rheumatology, St George Hospital, Sydney, New South Wales, Australia 10 Monash Department of Clinical ...

Academic Rheumatology, Clinical Sciences Building, Nottingham City Hospital, Nottingham, UK Correspondence to: Dr Edward Roddy Academic Rheumatology, Clinical Sciences Building, Nottingham City ...

Objectives To compare the use of glucocorticoids (GC) over time in patients with rheumatoid arthritis (RA) who were or were not treated initially with GC bridging therapy. Methods Data from the BeSt, ...

2 Department of Rheumatology, University of Sydney Institute of Bone and Joint Research, Royal North Shore Hospital, St Leonards, New South Wales, Australia 3 Department of Rheumatology, Royal ...

2 University Hospitals Birmingham NHS Foundation Trust, Department of Rheumatology, Birmingham, United Kingdom 3 University of Birmingham, Birmingham, United Kingdom 4 NIHR Birmingham Biomedical ...

1 Faculty of Health Sciences, University of Sydney, Lidcombe, New South Wales, Australia 2 Graduate School of Medicine, Notre Dame University, Darlinghurst, New South Wales, Australia 3 Covance Pty ...

Objectives Exploring the associations between disease activity and medications with offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus (SLE). Methods Data from the ...

Correspondence to Professor Masaaki Murakami, Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan; ...

Background Telitacicept (TACI-Fc fusion protein) is a novel BLyS (B-lymphocyte stimulator)/APRIL (a proliferation-inducing ligand) dual inhibitor, which has been approved in 2021 in China for the ...